FLJ44635: A Potential Drug Target and Biomarker (G392490)

Target Name: FLJ44635

NCBI ID: G392490

FLJ44635

Other Name(s): TPT1-like protein | TPT1L_HUMAN

FLJ44635: A Potential Drug Target and Biomarker

FLJ44635 is a protein that has been identified as a potential drug target and biomarker for the treatment of various diseases, including cancer. Its unique structure and function have made it an intriguing target for researchers to study, and its potential as a drug or biomarker has prompted a significant amount of interest in the field of biotechnology.

The protein in question is composed of 256 amino acids and has a molecular weight of 34 kDa. It is characterized by a N-terminus that contains a benzimidazole ring, which is known for its unique stability and resistance to various enzymes. also has a C-terminus that contains a benzimidazole ring and a conserved helical structure.

FLJ44635 has been shown to have various biological functions, including the regulation of cell growth, the development of new blood vessels, and the regulation of inflammation. Its ability to interact with various signaling pathways, including the TGF-β pathway, has led to its potential as a drug target.

One of the most significant aspects of FLJ44635 is its ability to induce apoptosis in various cell types. This process is known as cell death, and it can be a natural response to harmful stimuli, such as exposure to chemotherapy drugs or radiation. By inducing apoptosis , FLJ44635 may have the potential to become a valuable biomarker for the treatment of cancer.

FLJ44635 has also been shown to have a positive impact on various cellular processes, including cell adhesion, migration, and invasion. These properties make it an attractive target for the development of new therapies for a variety of diseases, including cancer.

In addition to its potential as a drug target, FLJ44635 has also been identified as a potential biomarker for a variety of diseases. Its ability to induce apoptosis in various cell types makes it an attractive target for the development of new diagnostic tools for cancer. Additionally , its positive impact on cellular processes makes it an attractive target for the development of new therapies for a variety of diseases, including cancer.

In conclusion, FLJ44635 is a protein that has shown a significant impact on various cellular processes and has the potential as a drug target and biomarker. Its unique structure and function have made it an intriguing target for researchers to study, and its potential as a drug or biomarker has generated a significant amount of interest in the field of biotechnology. Further research is needed to fully understand its potential and to develop new therapies based on its unique properties.

Protein Name: TPT1-like Protein

The "FLJ44635 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ44635 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets